Uncategorized Archives - Page 986 of 1028

FridayDec 16, 2016 12:07 pm

Net Element, Inc. (NASDAQ: NETE) Driving Transactions through High-Tech Channels

As one of the fastest-growing technology-driven companies enabling mobile payments and value-added transactional services, Net Element, Inc. (NASDAQ: NETE) is steadily carving out more and more of the global commerce pie. The South-Florida company currently has its sights set on certain key objectives: to empower smart payments through all channels of interaction between merchants and consumers, to establish multiple monetization channels for merchants and to add convenience and speed to everyday commerce. With subsidiaries like PayOnline under its umbrella, it is tactically positioned for substantial growth in the U.S. and in select emerging economies. Over the years, Net Element has…

FridayDec 16, 2016 11:23 am

PharmaCyte Biotech, Inc. (PMCB) Pre-IND Meeting with FDA Makes ATM Funding Possible

For California-based PharmaCyte Biotech, Inc. (OTCQB: PMCB), a light at the end of the pipeline tunnel has become visible as one piece of good news follows another. The approval by the FDA to entertain a Pre-Investigational New Drug (Pre-IND) submission from the company sent PMCB stock soaring to triple its pre-approval value. The resulting market cap made PharmaCyte ‘primarily eligible’ to register securities for sale in an at-the-market (ATM) offering, which it now plans to do through Chardan Capital. To make an ATM offering requires that the issuer be eligible, on a primary basis, to use a shelf registration statement…

FridayDec 16, 2016 9:12 am

Higher Price Target for Ocera Therapeutics (NASDAQ: OCRX) as Hepatic Encephalopathy Treatment Study Moves Forward

An innovative potential treatment for hepatic encephalopathy created by Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a unique product on an under-served market, and if clinical trials are successful, it could become a major source of success and profitability for the company, according to an Aegis Capital Corp. report (http://nnw.fm/cNkZ1) released on December 8. The report reiterates a ‘Buy’ rating for Ocera and recommends a higher stock price target of $8, compared to the $2.1 at the time of the analysis. The Aegis report was released a day after Ocera announced completion of enrollment in its phase 2B trials for lead…

ThursdayDec 15, 2016 3:01 pm

GainClients, Inc. (GCLT) Offering Buyers Simplified Home Search Tools with Comprehensive Results

U.S. home prices are going up steadily, having reached the highest peak in September after 2006’s real estate boom, a growth primarily driven by rising demand and a scarce inventory. The price hike came as a surprise to most real estate professionals, who expected a significant market slowdown in the last few months of 2016. While 2017 is likely to see more moderate growth, the market will continue to expand nonetheless, Realtor.com (http://nnw.fm/f4flB) experts believe, as two of America’s largest generations – Millennials and baby boomers, are reaching a stage in their lives that typically motivates people to buy a…

ThursdayDec 15, 2016 12:55 pm

NuVasive, Inc.’s (NASDAQ: NUVA) Speed of Innovation and Absolute Responsiveness form the Backbone of its Rapid Growth

How does a start-up venture capital-backed company grow its revenues to nearly a billion dollars in the global spine industry in less than two decades? By developing a competitive advantage in Speed of Innovation® and Absolute Responsiveness®, two concepts that have made NuVasive, Inc. (NASDAQ: NUVA) the number three company in the spine industry with over 90 products in its portfolio, including lumbar, thoracic, and cervical applications; neuromonitoring services; and biologics solutions. The global spinal implants and surgical devices market ‘is expected to reach USD 17.27 Billion by 2021, growing at a CAGR of 5.3% from 2016 to 2021’, according…

ThursdayDec 15, 2016 12:23 pm

Nano Dimension Ltd. (NASDAQ: NNDM) Revolutionizing the Way Electronics are Made with 3D Printing

Nano Dimension Ltd. (NASDAQ: NNDM) is the holding company for Nano Dimension Technology Ltd., a company in the business of researching, developing, and manufacturing three-dimensional (3D) printers for printed circuit boards (PCBs). The company also develops nano ink materials and other products for electronics. NNDM has the vision of revolutionizing the way electronics are made with 3D printing by using 3D printers for multilayer PCBs, along with advanced nanotechnology-based conductive and dielectric inks. Since the beginning of last year, Nano Dimension has won the Europe 2015 Award for Best Development in 3D Printing Equipment, the Gartner ‘Cool Vendor’ in 3D…

ThursdayDec 15, 2016 11:39 am

eXp World Holdings, Inc. (EXPI) Partners with MZ Group to Bolster Investor Relations and Outreach Efforts

Before the opening bell, eXp World Holdings, Inc. (OTCQB: EXPI), the holding company for The Agent-Owned Cloud Brokerage®, announced its retention of MZ Group as its investor relations advisor. Moving forward, MZ Group will assist and advise EXPI regarding its ongoing communications with shareholders with the aim of strengthening the company’s public brand and broadening its investor base. “We have chosen to partner with MZ Group to bolster our investor relations and outreach efforts during this time of rapid growth within our Company,” Glenn Sanford, founder, CEO and chairman of EXPI, stated in this morning’s news release. “While we have…

ThursdayDec 15, 2016 9:43 am

How to play the Dow 20K

Since the Dow is within spitting distance of breaking the 20,000 point level, for the first time, let’s look at what the pros are thinking. Jim Suva, Citi Research Analyst, forecast a "Tax reform benefit from reduction in corporate taxes and cash repatriation," as Citi Research reiterated its buy rating on Apple (NASDAQ: AAPL), while CNBC’s Jim Cramer added that IBM (NYSE: IBM) "would be a huge beneficiary of Trump's proposed lower corporate tax rates. It is a terrific play on a stronger economy.” So, it’s looking like the experts think that the Dow stalwarts are going to benefit from…

ThursdayDec 15, 2016 9:11 am

Hope for HIV Patients as CytoDyn Inc. (CYDY) Therapy Proves Efficacy during Clinical Trials

PRO 140, an innovative new therapy for HIV patients developed by CytoDyn Inc. (OTCQB: CYDY), is currently undergoing Phase 3 clinical trials, having been administered to several patients, according to a company press release (http://nnw.fm/a8eyJ). No other details were provided about the initial results of Phase 3 trials, but a separate report said actor Charlie Sheen is one of the subjects and that he has achieved undetectable viral load after taking PRO 140. Sheen, who revealed his HIV status in November last year, has been a part of the study for eight months and is receiving weekly injections of the…

WednesdayDec 14, 2016 3:41 pm

As Social Reality (NASDAQ: SRAX) Completes “Pivotal Year” New White Paper Suggests Trend in Programmatic Growth

Social Reality, Inc. (NASDAQ: SRAX) is an Internet advertising company that has developed SRAX, a real-time bidding (RTB) management platform that, among other capabilities, increases the efficiency with which online publishers are able to capitalize on programmatic advertising auctions. In November, a new whitepaper (http://nnw.fm/m3LAi) sponsored by Xaxis, in conjunction with IDC, expanded upon the notion that programmatic technology is rapidly spreading and redefining the way many brands are approaching advertising. Based on the whitepaper’s findings, nearly $15 billion was spent on brand campaigns based on automated platforms during 2015, with IDC estimating in excess of $100 billion in spending…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized